Top news of the week: 04.08.2021.
Startups
As Biology Manufacturing Company Zymergen Implodes, Correspondence With SEC Showed Early Doubts
Once backed by SoftBank Vision Fund with a blockbuster IPO in April, Zymergen announced it will have no revenue for this year or the next.
Biotech company Amgen to create 355 jobs in Wake County by 2025
Amgen plans to invest $550 million in a Holly Springs pharmaceutical manufacturing plant.
Veteran biotech executive to run new center aimed at boosting cell and gene therapies
Landmark Bio, a new center for advanced cell manufacturing, announced that former Orchard Therapeutics, Amgen, and Genzyme executive Ran Zheng will take over as chief executive. Landmark ...
24 biotech startups that are poised to take off
These are Insider's biggest healthcare stories for August 3.
Iterative Scopes Raises $30 Million Series A Financing to Advance AI-Driven Precision Medicine for Gastroenterology
Iterative Scopes closes $30M Series A to further develop core algorithmic innovations and bring cutting-edge precision medicine to gastroenterology.
Another day, another billion-dollar deal for PeptiDream, this time with Alnylam
Apparently a licensing agreement with Takeda worth a potential $3.5 billion wasn’t enough for PeptiDream this week. The biopharmaceutical company, which has a peptide-based drug discovery ...
Is Lab Meat About to Hit Your Dinner Plate?
Splashy headlines suggest it might be. But experts say it's still a “moonshot” away.
Why the life sciences leave people of color behind
And how COVID-19 and the Black Lives Matter movement could mark a turning point.